Complete Hematologic Remission (CHR)
1 clinical trials · Condition
◉ Watch Complete Hematologic Remission (CHR)
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL) (NCT02185781) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2015-01-28 |
Track Complete Hematologic Remission (CHR) automatically
Every clearance here is in the API, with alerts when new ones post.